March 17, 2021 – Strive Health announced that the company secured a $140 million Series B round of funding led by CapitalG, Alphabet’s independent growth fund. This brings Strive’s total funding to $223.5 million.
The financing will support the growing demand for Strive’s innovative whole-patient solution for kidney disease populations.
Strive say its model combines advanced technology with high-touch patient care to slow kidney disease progression, prevent unnecessary and costly hospitalizations, and expand access to optimal renal replacement therapies such as home dialysis and transplants.
The growing national spotlight on kidney care and the demand for value-based healthcare solutions has helped Strive more than double its presence in regional markets and grow its employee base by more than 600% in the last year.
The company said the new partnership with CapitalG is expected to amplify Strive’s position as the leader in value-based kidney care through growth capital and unique access to Google and Alphabet expertise to support product and go-to-market innovation.
The company has signed contracts to deliver its solution to leading healthcare payors and providers, including Humana, Blue Cross and Blue Shield of North Carolina, SSM Health, Conviva Care Centers and more.
Strive also has partnerships with hundreds of nephrology providers through new Medicare payment models and aggressive growth plans for the coming year.